Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Nov;6(Suppl 1):S51-S54.
doi: 10.1016/j.jobcr.2016.07.003. Epub 2016 Aug 8.

Salivary biomarkers in oral squamous cell carcinoma - An insight

Affiliations
Review

Salivary biomarkers in oral squamous cell carcinoma - An insight

T Radhika et al. J Oral Biol Craniofac Res. 2016 Nov.

Abstract

Oral cancer refers to the malignancies that occur in the oral cavity, lip and pharynx with 90% of oral cancers being squamous cell carcinomas (OSCC). OSCC has the highest mortality ratio compared to other carcinomas. Although oral cavity is easily accessible, most oral cancers are detected at a later stage leading to lower survival rates. Early detection of OSCC is a key factor in improving the prognosis and survival rate of the patient. Rapid advancement in the field of diagnosis has enabled early diagnosis of many potentially malignant conditions even before its clinical manifestations. One such diagnostic modality that has gained much relevance in the field of molecular biology has been the discovery of salivary biomarkers (DNA, RNA and protein markers). These salivary biomarkers have been shown to play a non-invasive role in the diagnosis and surveillance of oral cancer. The direct contact between the saliva and the oral cancer lesions makes it a most sensitive and specific, screening method in diagnosis, staging and follow-up. This review aims to discuss the effectiveness and the potential of salivary biomarkers as a screening tool in OSCC.

Keywords: Biomarkers; Oral cancer; Oral squamous cell carcinoma; Saliva.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Bano S., David M.P., Indira A.P. Salivary biomarkers for oral squamous cell carcinoma – an overview. IJSS Case Rep Rev. 2015;1(8):39–45.
    1. Spielmann N., Wong D.T. Saliva-diagnostics and therapeutic perspectives. Oral Dis. 2011;17(4):345–354. - PMC - PubMed
    1. Mishra A., Verma M. Cancer biomarkers – are we ready for the prime time? Cancers (Basel) 2010;2:190–208. - PMC - PubMed
    1. Tanaka T., Tanaka M., Tanaka T. Oral carcinogenesis and oral cancer chemoprevention – a review. J Pathol Res Int. 2011:1–10. - PMC - PubMed
    1. Shah F.D., Begum R., Vajaria B.N. A review on salivary genomics and proteomics biomarkers in oral cancer. Indian J Clin Biochem. 2011;26(4):326–334. - PMC - PubMed

LinkOut - more resources